Your browser doesn't support javascript.
loading
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar, Maryam; Chahardouli, Bahram; Biglari, Alireza; Ahmadvand, Mohammad; Bahri, Tanaz; Alaeddini, Farshid; Sharifi Aliabadi, Leyla; Noorani, Seied Saeid; Bagheri Amiri, Fahimeh; Biglari, Mohammad; Shemshadi, Mohammad Reza; Ghavamzadeh, Ardeshir; Vaezi, Mohammad.
Affiliation
  • Barkhordar M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Chahardouli B; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Biglari A; Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadvand M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Bahri T; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Alaeddini F; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Sharifi Aliabadi L; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Noorani SS; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Bagheri Amiri F; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
  • Biglari M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Shemshadi MR; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghavamzadeh A; Cancer & Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Vaezi M; Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Front Immunol ; 14: 1169666, 2023.
Article in En | MEDLINE | ID: mdl-37153556
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Vaccines / COVID-19 Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Suiza